Chemotherapy induces multiple sclerosis-like neuropathologies that can be rescued by clobetasol
Authors:
- 12 December 2025
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 33 (6) , 1281-1291
Abstract
Chemotherapy is essential for cancer management yet frequently accompanied with adverse effects, particularly for temozolomide (TMZ), a frontline chemotherapeutic agent for glioma. Although clinical neurological abnormalities linked to TMZ have been observed, mechanisms underlying TMZ-induced neural impairments remain poorly understood, and effective interventions are lacking. Here, we demonstrated that TMZ chemotherapy induced neurodegenerations that recapitulated pathological features of multiple sclerosis, including demyelination, neuroinflammation and axonal degeneration. In adolescent mice, TMZ treatment resulted in severe white matter damage that spontaneously recovered, whereas in adult mice, moderate myelin damage persisted without recovery within the same timeframe. Importantly, we identified that clobetasol effectively reversed TMZ-induced white matter damage and trends toward anxiety and depression in adult mice by suppressing TMZ-induced AMPK activation and attenuating neuroinflammation, thereby promoting remyelination. Our findings reveal the previously underappreciated neural toxicities associated with TMZ chemotherapy and highlight the therapeutic efficacy of clobetasol in mitigating chemotherapy-induced neural impairment, providing a strategy to enhance the life quality of cancer patients.Keywords
Funding Information
- National Natural Science Foundation of China (81571195)
- National Natural Science Foundation of China (82372836)
- National Natural Science Foundation of China (82272644)
This publication has 46 references indexed in Scilit:
- Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre studyJournal of Neuro-Oncology, 2023
- World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type GliomasJAMA Oncology, 2022
- Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomasJournal of Neuro-Oncology, 2022
- Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive ImpairmentCell, 2019
- AMPK Negatively Regulates Peripheral Myelination via Activation of c-JunMolecular Neurobiology, 2016
- Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous systemCurrent Opinion in Cell Biology, 2015
- Chemotherapy‐induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patientsHuman Brain Mapping, 2011
- ‘Chemobrain’ in breast carcinoma?Cancer, 2004
- Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinomaCancer, 1999
- Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancerPsycho-Oncology, 1995